Skip to main content
. 2022 Feb 25;9:767987. doi: 10.3389/fcvm.2022.767987

Figure 3.

Figure 3

(A) Composition proportion of the identified signals. (B) Association between several highlighted adverse events and different proton pump inhibitor drugs quantified by the information components value.